Abnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients
Abstract High rate of cardiovascular disease (CVD) has been reported among patients with coronavirus disease 2019 (COVID-19). Importantly, CVD, as one of the comorbidities, could also increase the risks of the severity of COVID-19. Here we identified phospholipase A2 group VII (PLA2G7), a well-studi...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/faa16bffd183431c8efb485d73e2546d |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:faa16bffd183431c8efb485d73e2546d |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:faa16bffd183431c8efb485d73e2546d2021-12-02T16:35:56ZAbnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients10.1038/s41598-021-85848-52045-2322https://doaj.org/article/faa16bffd183431c8efb485d73e2546d2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85848-5https://doaj.org/toc/2045-2322Abstract High rate of cardiovascular disease (CVD) has been reported among patients with coronavirus disease 2019 (COVID-19). Importantly, CVD, as one of the comorbidities, could also increase the risks of the severity of COVID-19. Here we identified phospholipase A2 group VII (PLA2G7), a well-studied CVD biomarker, as a hub gene in COVID-19 though an integrated hypothesis-free genomic analysis on nasal swabs (n = 486) from patients with COVID-19. PLA2G7 was further found to be predominantly expressed by proinflammatory macrophages in lungs emerging with progression of COVID-19. In the validation stage, RNA level of PLA2G7 was identified in nasal swabs from both COVID-19 and pneumonia patients, other than health individuals. The positive rate of PLA2G7 were correlated with not only viral loads but also severity of pneumonia in non-COVID-19 patients. Serum protein levels of PLA2G7 were found to be elevated and beyond the normal limit in COVID-19 patients, especially among those re-positive patients. We identified and validated PLA2G7, a biomarker for CVD, was abnormally enhanced in COVID-19 at both nucleotide and protein aspects. These findings provided indications into the prevalence of cardiovascular involvements seen in patients with COVID-19. PLA2G7 could be a potential prognostic and therapeutic target in COVID-19.Yang LiYongzhong JiangYi ZhangNaizhe LiQiangling YinLinlin LiuXin LvYan LiuAqian LiBin FangJiajia LiHengping YeGang YangXiaoxian CuiYang LiuYuanyuan QuChuan LiJiandong LiDexin LiZhongtao GaiShiwen WangFaxian ZhanMifang LiangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Yang Li Yongzhong Jiang Yi Zhang Naizhe Li Qiangling Yin Linlin Liu Xin Lv Yan Liu Aqian Li Bin Fang Jiajia Li Hengping Ye Gang Yang Xiaoxian Cui Yang Liu Yuanyuan Qu Chuan Li Jiandong Li Dexin Li Zhongtao Gai Shiwen Wang Faxian Zhan Mifang Liang Abnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients |
| description |
Abstract High rate of cardiovascular disease (CVD) has been reported among patients with coronavirus disease 2019 (COVID-19). Importantly, CVD, as one of the comorbidities, could also increase the risks of the severity of COVID-19. Here we identified phospholipase A2 group VII (PLA2G7), a well-studied CVD biomarker, as a hub gene in COVID-19 though an integrated hypothesis-free genomic analysis on nasal swabs (n = 486) from patients with COVID-19. PLA2G7 was further found to be predominantly expressed by proinflammatory macrophages in lungs emerging with progression of COVID-19. In the validation stage, RNA level of PLA2G7 was identified in nasal swabs from both COVID-19 and pneumonia patients, other than health individuals. The positive rate of PLA2G7 were correlated with not only viral loads but also severity of pneumonia in non-COVID-19 patients. Serum protein levels of PLA2G7 were found to be elevated and beyond the normal limit in COVID-19 patients, especially among those re-positive patients. We identified and validated PLA2G7, a biomarker for CVD, was abnormally enhanced in COVID-19 at both nucleotide and protein aspects. These findings provided indications into the prevalence of cardiovascular involvements seen in patients with COVID-19. PLA2G7 could be a potential prognostic and therapeutic target in COVID-19. |
| format |
article |
| author |
Yang Li Yongzhong Jiang Yi Zhang Naizhe Li Qiangling Yin Linlin Liu Xin Lv Yan Liu Aqian Li Bin Fang Jiajia Li Hengping Ye Gang Yang Xiaoxian Cui Yang Liu Yuanyuan Qu Chuan Li Jiandong Li Dexin Li Zhongtao Gai Shiwen Wang Faxian Zhan Mifang Liang |
| author_facet |
Yang Li Yongzhong Jiang Yi Zhang Naizhe Li Qiangling Yin Linlin Liu Xin Lv Yan Liu Aqian Li Bin Fang Jiajia Li Hengping Ye Gang Yang Xiaoxian Cui Yang Liu Yuanyuan Qu Chuan Li Jiandong Li Dexin Li Zhongtao Gai Shiwen Wang Faxian Zhan Mifang Liang |
| author_sort |
Yang Li |
| title |
Abnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients |
| title_short |
Abnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients |
| title_full |
Abnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients |
| title_fullStr |
Abnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients |
| title_full_unstemmed |
Abnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients |
| title_sort |
abnormal upregulation of cardiovascular disease biomarker pla2g7 induced by proinflammatory macrophages in covid-19 patients |
| publisher |
Nature Portfolio |
| publishDate |
2021 |
| url |
https://doaj.org/article/faa16bffd183431c8efb485d73e2546d |
| work_keys_str_mv |
AT yangli abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT yongzhongjiang abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT yizhang abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT naizheli abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT qianglingyin abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT linlinliu abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT xinlv abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT yanliu abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT aqianli abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT binfang abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT jiajiali abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT hengpingye abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT gangyang abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT xiaoxiancui abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT yangliu abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT yuanyuanqu abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT chuanli abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT jiandongli abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT dexinli abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT zhongtaogai abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT shiwenwang abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT faxianzhan abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients AT mifangliang abnormalupregulationofcardiovasculardiseasebiomarkerpla2g7inducedbyproinflammatorymacrophagesincovid19patients |
| _version_ |
1718383730699010048 |